HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 3,937.272 million compared to CNY 3,457.292 million a year ago. Operating income was CNY 189.519 million compared to CNY 178.660 million a year ago. Net income was CNY 140.559 million compared to CNY 134.214 million a year ago. Basic earnings per share from continuing operations was CNY 0.2424 compared to CNY 0.2314 a year ago.